Developing new treatments for infectious diseases
Task D18: Non-Clinical Services for Development of Interventional Agents for Infectious Diseases
This study is working on developing new medicines to help fight infections caused by germs and toxins, making sure they are safe and effective before they are tested in people.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project ID | NIH-11202402 on NIH RePORTER |
What this research studies
This research focuses on creating and evaluating new therapeutic agents aimed at combating infectious diseases caused by various pathogens and toxins. It involves a series of preclinical services, including planning, lead identification, and rigorous testing of drug safety and effectiveness both in laboratory settings and in living organisms. By utilizing advanced manufacturing techniques and thorough pharmacokinetic studies, the program aims to ensure that these new treatments are both safe and effective before they reach clinical trials.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by infectious diseases or those at high risk of exposure to infectious pathogens.
Not a fit: Patients with non-infectious diseases or those not affected by infectious pathogens may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective new therapies for infectious diseases, improving patient outcomes and public health.
How similar studies have performed: Previous research has shown success in developing therapeutic agents for infectious diseases using similar preclinical approaches.
Where this research is happening
Menlo Park, United States
- Sri International — Menlo Park, United States (Active)
Researchers
- Principal investigator: Mirsalis, Jon — Sri International
- Study coordinator: Mirsalis, Jon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.